Alexza Pharmaceuticals, Inc.
Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 Staccato Loxapine in North America
Published in Lab Business Week, February 28th, 2010
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced that it has established a collaboration with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation (NYSE:BVF), to develop and commercialize AZ-004 (Staccato® loxapine) in the U.S. and Canada. AZ-004 is Alexza's lead program, based on the company's proprietary technology, the Staccato system. Alexza submitted its New Drug Application (NDA) for Staccato loxapine in December 2009. Alexza is seeking regulatory approval to market AZ-004, an inhalation product candidate developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder.
"We are very excited to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2010-02-28)
More Articles from Lab Business Week
- Agendia B.V.
Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists - Allegheny General Hospital
Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment - BioCrossroads
Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges - Bionovo, Inc.
Dr. Paul Pui-Hay But, Ph.D. Joins Bionovo, Inc. Scientific Advisory Board - Biovail Corporation
Biovail Enters into License and Collaboration Agreement with Alexza for AZ-004 - Body Weight
Research from Covance Inc. in the area of body weight published - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
